- Autor
-
Pracoviště
Department of Clinical Biochemistry U... 1 Department of Neurology 2nd Faculty o... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Paediatric Neurology Ma... 1 Faculty of Medicine Masaryk Universit... 1 Faculty of Medicine Masaryk Universit... 1 Institute of Biostatistics and Analys... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
- Autor
-
Pracoviště
Department of Clinical Biochemistry U... 1 Department of Neurology 2nd Faculty o... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Neurology University Ho... 1 Department of Paediatric Neurology Ma... 1 Faculty of Medicine Masaryk Universit... 1 Faculty of Medicine Masaryk Universit... 1 Institute of Biostatistics and Analys... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
PubMed Central od 2013 do Před 2 týdny
Europe PubMed Central od 2013
Open Access Digital Library od 2013-01-01
Open Access Digital Library od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources od 1922
PubMed
32502004
DOI
10.1097/md.0000000000020523
Knihovny.cz E-zdroje
Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-Müllerian hormone) is currently considered the best measure of ovarian reserve.A total of 21 females with myotonic dystrophy type 1 (MD1), 25 females with myotonic dystrophy type 2 (MD2), 12 females with facioscapulohumeral muscular dystrophy (FSHD), 12 female carriers of Duchenne muscular dystrophy mutations (cDMD) and 86 age-matched healthy controls of reproductive age (range 18 - 44 years) were included in this case control study. An enzymatically amplified 2-site immunoassay was used to measure serum AMH level.The MD1 group shows a significant decrease of AMH values (median 0.7 ng/mL; range 0 - 4.9 ng/mL) compared with age-matched healthy controls (P < .01). AMH levels were similar between patients and controls in terms of females with MD2 (P = .98), FSHD (P = .55) and cDMD (P = .60).This study suggests decreased ovarian reserve in women with MD1, but not in MD2, FSHD and cDMD.
- MeSH
- antimülleriánský hormon krev MeSH
- biologické markery krev MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- ovariální rezerva * MeSH
- prospektivní studie MeSH
- studie případů a kontrol MeSH
- svalové dystrofie krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.